A new trading day began on Tuesday, with Atossa Therapeutics Inc (NASDAQ: ATOS) stock price up 7.09% from the previous day of trading, before settling in for the closing price of $0.74. ATOS’s price has ranged from $0.55 to $1.81 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -26.67%. With a float of $129.13 million, this company’s outstanding shares have now reached $129.17 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atossa Therapeutics Inc (ATOS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Atossa Therapeutics Inc is 0.03%, while institutional ownership is 27.62%. The most recent insider transaction that took place on Mar 26 ’25, was worth 7,000. In this transaction Director of this company bought 10,000 shares at a rate of $0.70, taking the stock ownership to the 10,257 shares.
Atossa Therapeutics Inc (ATOS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -26.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.87% during the next five years compared to 36.92% growth over the previous five years of trading.
Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators
Here are Atossa Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Atossa Therapeutics Inc (ATOS)
Looking closely at Atossa Therapeutics Inc (NASDAQ: ATOS), its last 5-days average volume was 0.69 million, which is a jump from its year-to-date volume of 0.66 million. As of the previous 9 days, the stock’s Stochastic %D was 90.41%. Additionally, its Average True Range was 0.06.
During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 32.58%, which indicates a significant decrease from 94.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.81% in the past 14 days, which was higher than the 63.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7122, while its 200-day Moving Average is $1.1091. However, in the short run, Atossa Therapeutics Inc’s stock first resistance to watch stands at $0.8306. Second resistance stands at $0.8657. The third major resistance level sits at $0.9210. If the price goes on to break the first support level at $0.7402, it is likely to go to the next support level at $0.6849. Now, if the price goes above the second support level, the third support stands at $0.6498.
Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats
With a market capitalization of 102.75 million, the company has a total of 129,170K Shares Outstanding. Currently, annual sales are 0 K while annual income is -25,500 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,350 K.
